BTK and leukemia: According to the literature, spleen tyrosine kinase (SYK), phosphoinositide 3’kinase (PI3K), and Bruton’s tyrosine kinase (BTK) were selected because they have been related to decrease of leukemia cells [62,63,64] in preclinical models.